Earnings Call Intelligence Subscribe
Home › Call Sheets › DXCM › Q2'26
Call sheet · Q2'26

DexCom (DXCM)

Q2'26 earnings call · held July 30, 2026 · compared with the Q1'26 call · management-credibility review
6/12
Disclosure score
4 medium, 4 low flags
Financial quality
Bottom line
The market's celebrating margin beats while missing that DexCom just paid up for a tiny nutrition app because their core CGM adoption is stalling. Management's '50% converted to 15-day by year-end' target reveals they're only at 25-30% now, way behind the victory lap they took in Q1. The binding constraint isn't coverage anymore, it's that even with 7M covered Type 2 lives, they can't crack the utilization code, hence the desperate NutriSense deal. Most revealing quote: revenues from NutriSense are 'millions you can count on one hand', yet they did the deal anyway. My view changes if CMS announces Type 2 coverage before year-end rather than mid-2027, but management's body language suggests they already know that timeline.

The 30-second version

  • The sleeper story: 50% conversion to 15-day by year-end is actually below plan
  • 13% revenue growth masks a US deceleration hidden by FX headwinds
  • NutriSense acquisition signals desperation to juice engagement metrics

What changed this quarter

MetricQ1'26Q2'26Change
Revenue$1.19B (15% YoY)$1.31B (13% YoY)200 bps deceleration
US Revenue$832M (11% YoY)$933M (11% YoY)Flat growth rate
International Revenue$360M (26% YoY)$375M (19% YoY)700 bps deceleration
Organic Revenue Growth12%12%No acceleration despite 15-day
Gross Margin63.5%64.1%+60 bps improvement
Operating Margin22.2%25.1%+290 bps expansion
EPS$0.56$0.70+25% growth
Net Income$216.3M$269.1M+24% growth
Adjusted EBITDA Margin30.6%32.2%+160 bps expansion
Free Cash Flow (H1)Not disclosed$600M+Doubled from H1 2025

Accountability tracked

7 new promises made4 narrative shifts flagged6 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full DXCM Q2'26 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.